 | • レポートコード：MRC2-11QY04883 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は経皮ドラッグデリバリーシステムのグローバル市場について調査・分析したレポートです。種類別（フェンタニル、ニトログリセリン、エストラジオール、ニコチン、その他）市場規模、用途別（OTC、Rx）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別経皮ドラッグデリバリーシステムの競争状況、市場シェア ・世界の経皮ドラッグデリバリーシステム市場：種類別市場規模 2015年-2020年（フェンタニル、ニトログリセリン、エストラジオール、ニコチン、その他） ・世界の経皮ドラッグデリバリーシステム市場：種類別市場規模予測 2021年-2026年（フェンタニル、ニトログリセリン、エストラジオール、ニコチン、その他） ・世界の経皮ドラッグデリバリーシステム市場：用途別市場規模 2015年-2020年（OTC、Rx） ・世界の経皮ドラッグデリバリーシステム市場：用途別市場規模予測 2021年-2026年（OTC、Rx） ・北米の経皮ドラッグデリバリーシステム市場分析：米国、カナダ ・ヨーロッパの経皮ドラッグデリバリーシステム市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの経皮ドラッグデリバリーシステム市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の経皮ドラッグデリバリーシステム市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの経皮ドラッグデリバリーシステム市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Hisamitsu、Mylan、GSK、Novartis、Teve(Actavis)、Johnson & Johnson、UCB、Teikoku Seiyaku、Bayer、Lingrui、Sanofi、Qizheng、Endo、Huarun 999、Haw Par、Nichiban、Mentholatum Company、Laboratoires Genevrier ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
Market Analysis and Insights: Global Transdermal Drug Delivery Systems Market
The global Transdermal Drug Delivery Systems market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Transdermal Drug Delivery Systems Scope and Market Size
Transdermal Drug Delivery Systems market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Transdermal Drug Delivery Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Hisamitsu
Mylan
GSK
Novartis
Teve(Actavis)
Johnson & Johnson
UCB
Teikoku Seiyaku
Bayer
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum Company
Laboratoires Genevrier
Market segment by Type, the product can be split into
Fentanyl
Nitroglycerin
Estradiol
Nicotine
Other
Market segment by Application, split into
OTC
Rx
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Transdermal Drug Delivery Systems Revenue
1.4 Market by Type
1.4.1 Global Transdermal Drug Delivery Systems Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Fentanyl
1.4.3 Nitroglycerin
1.4.4 Estradiol
1.4.5 Nicotine
1.4.6 Other
1.5 Market by Application
1.5.1 Global Transdermal Drug Delivery Systems Market Share by Application: 2020 VS 2026
1.5.2 OTC
1.5.3 Rx
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Transdermal Drug Delivery Systems Market Perspective (2015-2026)
2.2 Global Transdermal Drug Delivery Systems Growth Trends by Regions
2.2.1 Transdermal Drug Delivery Systems Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Transdermal Drug Delivery Systems Historic Market Share by Regions (2015-2020)
2.2.3 Transdermal Drug Delivery Systems Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Transdermal Drug Delivery Systems Market Growth Strategy
2.3.6 Primary Interviews with Key Transdermal Drug Delivery Systems Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Transdermal Drug Delivery Systems Players by Market Size
3.1.1 Global Top Transdermal Drug Delivery Systems Players by Revenue (2015-2020)
3.1.2 Global Transdermal Drug Delivery Systems Revenue Market Share by Players (2015-2020)
3.1.3 Global Transdermal Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Transdermal Drug Delivery Systems Market Concentration Ratio
3.2.1 Global Transdermal Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Transdermal Drug Delivery Systems Revenue in 2019
3.3 Transdermal Drug Delivery Systems Key Players Head office and Area Served
3.4 Key Players Transdermal Drug Delivery Systems Product Solution and Service
3.5 Date of Enter into Transdermal Drug Delivery Systems Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Transdermal Drug Delivery Systems Historic Market Size by Type (2015-2020)
4.2 Global Transdermal Drug Delivery Systems Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Transdermal Drug Delivery Systems Market Size by Application (2015-2020)
5.2 Global Transdermal Drug Delivery Systems Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Transdermal Drug Delivery Systems Market Size (2015-2020)
6.2 Transdermal Drug Delivery Systems Key Players in North America (2019-2020)
6.3 North America Transdermal Drug Delivery Systems Market Size by Type (2015-2020)
6.4 North America Transdermal Drug Delivery Systems Market Size by Application (2015-2020)
7 Europe
7.1 Europe Transdermal Drug Delivery Systems Market Size (2015-2020)
7.2 Transdermal Drug Delivery Systems Key Players in Europe (2019-2020)
7.3 Europe Transdermal Drug Delivery Systems Market Size by Type (2015-2020)
7.4 Europe Transdermal Drug Delivery Systems Market Size by Application (2015-2020)
8 China
8.1 China Transdermal Drug Delivery Systems Market Size (2015-2020)
8.2 Transdermal Drug Delivery Systems Key Players in China (2019-2020)
8.3 China Transdermal Drug Delivery Systems Market Size by Type (2015-2020)
8.4 China Transdermal Drug Delivery Systems Market Size by Application (2015-2020)
9 Japan
9.1 Japan Transdermal Drug Delivery Systems Market Size (2015-2020)
9.2 Transdermal Drug Delivery Systems Key Players in Japan (2019-2020)
9.3 Japan Transdermal Drug Delivery Systems Market Size by Type (2015-2020)
9.4 Japan Transdermal Drug Delivery Systems Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Transdermal Drug Delivery Systems Market Size (2015-2020)
10.2 Transdermal Drug Delivery Systems Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Transdermal Drug Delivery Systems Market Size by Type (2015-2020)
10.4 Southeast Asia Transdermal Drug Delivery Systems Market Size by Application (2015-2020)
11 India
11.1 India Transdermal Drug Delivery Systems Market Size (2015-2020)
11.2 Transdermal Drug Delivery Systems Key Players in India (2019-2020)
11.3 India Transdermal Drug Delivery Systems Market Size by Type (2015-2020)
11.4 India Transdermal Drug Delivery Systems Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Transdermal Drug Delivery Systems Market Size (2015-2020)
12.2 Transdermal Drug Delivery Systems Key Players in Central & South America (2019-2020)
12.3 Central & South America Transdermal Drug Delivery Systems Market Size by Type (2015-2020)
12.4 Central & South America Transdermal Drug Delivery Systems Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Hisamitsu
13.1.1 Hisamitsu Company Details
13.1.2 Hisamitsu Business Overview
13.1.3 Hisamitsu Transdermal Drug Delivery Systems Introduction
13.1.4 Hisamitsu Revenue in Transdermal Drug Delivery Systems Business (2015-2020))
13.1.5 Hisamitsu Recent Development
13.2 Mylan
13.2.1 Mylan Company Details
13.2.2 Mylan Business Overview
13.2.3 Mylan Transdermal Drug Delivery Systems Introduction
13.2.4 Mylan Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
13.2.5 Mylan Recent Development
13.3 GSK
13.3.1 GSK Company Details
13.3.2 GSK Business Overview
13.3.3 GSK Transdermal Drug Delivery Systems Introduction
13.3.4 GSK Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
13.3.5 GSK Recent Development
13.4 Novartis
13.4.1 Novartis Company Details
13.4.2 Novartis Business Overview
13.4.3 Novartis Transdermal Drug Delivery Systems Introduction
13.4.4 Novartis Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
13.4.5 Novartis Recent Development
13.5 Teve(Actavis)
13.5.1 Teve(Actavis) Company Details
13.5.2 Teve(Actavis) Business Overview
13.5.3 Teve(Actavis) Transdermal Drug Delivery Systems Introduction
13.5.4 Teve(Actavis) Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
13.5.5 Teve(Actavis) Recent Development
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Details
13.6.2 Johnson & Johnson Business Overview
13.6.3 Johnson & Johnson Transdermal Drug Delivery Systems Introduction
13.6.4 Johnson & Johnson Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
13.6.5 Johnson & Johnson Recent Development
13.7 UCB
13.7.1 UCB Company Details
13.7.2 UCB Business Overview
13.7.3 UCB Transdermal Drug Delivery Systems Introduction
13.7.4 UCB Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
13.7.5 UCB Recent Development
13.8 Teikoku Seiyaku
13.8.1 Teikoku Seiyaku Company Details
13.8.2 Teikoku Seiyaku Business Overview
13.8.3 Teikoku Seiyaku Transdermal Drug Delivery Systems Introduction
13.8.4 Teikoku Seiyaku Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
13.8.5 Teikoku Seiyaku Recent Development
13.9 Bayer
13.9.1 Bayer Company Details
13.9.2 Bayer Business Overview
13.9.3 Bayer Transdermal Drug Delivery Systems Introduction
13.9.4 Bayer Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
13.9.5 Bayer Recent Development
13.10 Lingrui
13.10.1 Lingrui Company Details
13.10.2 Lingrui Business Overview
13.10.3 Lingrui Transdermal Drug Delivery Systems Introduction
13.10.4 Lingrui Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
13.10.5 Lingrui Recent Development
13.11 Sanofi
10.11.1 Sanofi Company Details
10.11.2 Sanofi Business Overview
10.11.3 Sanofi Transdermal Drug Delivery Systems Introduction
10.11.4 Sanofi Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
10.11.5 Sanofi Recent Development
13.12 Qizheng
10.12.1 Qizheng Company Details
10.12.2 Qizheng Business Overview
10.12.3 Qizheng Transdermal Drug Delivery Systems Introduction
10.12.4 Qizheng Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
10.12.5 Qizheng Recent Development
13.13 Endo
10.13.1 Endo Company Details
10.13.2 Endo Business Overview
10.13.3 Endo Transdermal Drug Delivery Systems Introduction
10.13.4 Endo Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
10.13.5 Endo Recent Development
13.14 Huarun 999
10.14.1 Huarun 999 Company Details
10.14.2 Huarun 999 Business Overview
10.14.3 Huarun 999 Transdermal Drug Delivery Systems Introduction
10.14.4 Huarun 999 Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
10.14.5 Huarun 999 Recent Development
13.15 Haw Par
10.15.1 Haw Par Company Details
10.15.2 Haw Par Business Overview
10.15.3 Haw Par Transdermal Drug Delivery Systems Introduction
10.15.4 Haw Par Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
10.15.5 Haw Par Recent Development
13.16 Nichiban
10.16.1 Nichiban Company Details
10.16.2 Nichiban Business Overview
10.16.3 Nichiban Transdermal Drug Delivery Systems Introduction
10.16.4 Nichiban Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
10.16.5 Nichiban Recent Development
13.17 Mentholatum Company
10.17.1 Mentholatum Company Company Details
10.17.2 Mentholatum Company Business Overview
10.17.3 Mentholatum Company Transdermal Drug Delivery Systems Introduction
10.17.4 Mentholatum Company Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
10.17.5 Mentholatum Company Recent Development
13.18 Laboratoires Genevrier
10.18.1 Laboratoires Genevrier Company Details
10.18.2 Laboratoires Genevrier Business Overview
10.18.3 Laboratoires Genevrier Transdermal Drug Delivery Systems Introduction
10.18.4 Laboratoires Genevrier Revenue in Transdermal Drug Delivery Systems Business (2015-2020)
10.18.5 Laboratoires Genevrier Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Transdermal Drug Delivery Systems Key Market Segments
Table 2. Key Players Covered: Ranking by Transdermal Drug Delivery Systems Revenue
Table 3. Ranking of Global Top Transdermal Drug Delivery Systems Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Transdermal Drug Delivery Systems Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Fentanyl
Table 6. Key Players of Nitroglycerin
Table 7. Key Players of Estradiol
Table 8. Key Players of Nicotine
Table 9. Key Players of Other
Table 10. Global Transdermal Drug Delivery Systems Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Transdermal Drug Delivery Systems Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Transdermal Drug Delivery Systems Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Transdermal Drug Delivery Systems Market Share by Regions (2015-2020)
Table 14. Global Transdermal Drug Delivery Systems Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Transdermal Drug Delivery Systems Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Transdermal Drug Delivery Systems Market Growth Strategy
Table 20. Main Points Interviewed from Key Transdermal Drug Delivery Systems Players
Table 21. Global Transdermal Drug Delivery Systems Revenue by Players (2015-2020) (Million US$)
Table 22. Global Transdermal Drug Delivery Systems Market Share by Players (2015-2020)
Table 23. Global Top Transdermal Drug Delivery Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Drug Delivery Systems as of 2019)
Table 24. Global Transdermal Drug Delivery Systems by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Transdermal Drug Delivery Systems Product Solution and Service
Table 27. Date of Enter into Transdermal Drug Delivery Systems Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Transdermal Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 30. Global Transdermal Drug Delivery Systems Market Size Share by Type (2015-2020)
Table 31. Global Transdermal Drug Delivery Systems Revenue Market Share by Type (2021-2026)
Table 32. Global Transdermal Drug Delivery Systems Market Size Share by Application (2015-2020)
Table 33. Global Transdermal Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 34. Global Transdermal Drug Delivery Systems Market Size Share by Application (2021-2026)
Table 35. North America Key Players Transdermal Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Transdermal Drug Delivery Systems Market Share (2019-2020)
Table 37. North America Transdermal Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 38. North America Transdermal Drug Delivery Systems Market Share by Type (2015-2020)
Table 39. North America Transdermal Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 40. North America Transdermal Drug Delivery Systems Market Share by Application (2015-2020)
Table 41. Europe Key Players Transdermal Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Transdermal Drug Delivery Systems Market Share (2019-2020)
Table 43. Europe Transdermal Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Transdermal Drug Delivery Systems Market Share by Type (2015-2020)
Table 45. Europe Transdermal Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Transdermal Drug Delivery Systems Market Share by Application (2015-2020)
Table 47. China Key Players Transdermal Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 48. China Key Players Transdermal Drug Delivery Systems Market Share (2019-2020)
Table 49. China Transdermal Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 50. China Transdermal Drug Delivery Systems Market Share by Type (2015-2020)
Table 51. China Transdermal Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 52. China Transdermal Drug Delivery Systems Market Share by Application (2015-2020)
Table 53. Japan Key Players Transdermal Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Transdermal Drug Delivery Systems Market Share (2019-2020)
Table 55. Japan Transdermal Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Transdermal Drug Delivery Systems Market Share by Type (2015-2020)
Table 57. Japan Transdermal Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Transdermal Drug Delivery Systems Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Transdermal Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Transdermal Drug Delivery Systems Market Share (2019-2020)
Table 61. Southeast Asia Transdermal Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Transdermal Drug Delivery Systems Market Share by Type (2015-2020)
Table 63. Southeast Asia Transdermal Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Transdermal Drug Delivery Systems Market Share by Application (2015-2020)
Table 65. India Key Players Transdermal Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 66. India Key Players Transdermal Drug Delivery Systems Market Share (2019-2020)
Table 67. India Transdermal Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 68. India Transdermal Drug Delivery Systems Market Share by Type (2015-2020)
Table 69. India Transdermal Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 70. India Transdermal Drug Delivery Systems Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Transdermal Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Transdermal Drug Delivery Systems Market Share (2019-2020)
Table 73. Central & South America Transdermal Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Transdermal Drug Delivery Systems Market Share by Type (2015-2020)
Table 75. Central & South America Transdermal Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Transdermal Drug Delivery Systems Market Share by Application (2015-2020)
Table 77. Hisamitsu Company Details
Table 78. Hisamitsu Business Overview
Table 79. Hisamitsu Product
Table 80. Hisamitsu Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 81. Hisamitsu Recent Development
Table 82. Mylan Company Details
Table 83. Mylan Business Overview
Table 84. Mylan Product
Table 85. Mylan Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 86. Mylan Recent Development
Table 87. GSK Company Details
Table 88. GSK Business Overview
Table 89. GSK Product
Table 90. GSK Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 91. GSK Recent Development
Table 92. Novartis Company Details
Table 93. Novartis Business Overview
Table 94. Novartis Product
Table 95. Novartis Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 96. Novartis Recent Development
Table 97. Teve(Actavis) Company Details
Table 98. Teve(Actavis) Business Overview
Table 99. Teve(Actavis) Product
Table 100. Teve(Actavis) Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 101. Teve(Actavis) Recent Development
Table 102. Johnson & Johnson Company Details
Table 103. Johnson & Johnson Business Overview
Table 104. Johnson & Johnson Product
Table 105. Johnson & Johnson Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 106. Johnson & Johnson Recent Development
Table 107. UCB Company Details
Table 108. UCB Business Overview
Table 109. UCB Product
Table 110. UCB Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 111. UCB Recent Development
Table 112. Teikoku Seiyaku Business Overview
Table 113. Teikoku Seiyaku Product
Table 114. Teikoku Seiyaku Company Details
Table 115. Teikoku Seiyaku Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 116. Teikoku Seiyaku Recent Development
Table 117. Bayer Company Details
Table 118. Bayer Business Overview
Table 119. Bayer Product
Table 120. Bayer Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 121. Bayer Recent Development
Table 122. Lingrui Company Details
Table 123. Lingrui Business Overview
Table 124. Lingrui Product
Table 125. Lingrui Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 126. Lingrui Recent Development
Table 127. Sanofi Company Details
Table 128. Sanofi Business Overview
Table 129. Sanofi Product
Table 130. Sanofi Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 131. Sanofi Recent Development
Table 132. Qizheng Company Details
Table 133. Qizheng Business Overview
Table 134. Qizheng Product
Table 135. Qizheng Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 136. Qizheng Recent Development
Table 137. Endo Company Details
Table 138. Endo Business Overview
Table 139. Endo Product
Table 140. Endo Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 141. Endo Recent Development
Table 142. Huarun 999 Company Details
Table 143. Huarun 999 Business Overview
Table 144. Huarun 999 Product
Table 145. Huarun 999 Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 146. Huarun 999 Recent Development
Table 147. Haw Par Company Details
Table 148. Haw Par Business Overview
Table 149. Haw Par Product
Table 150. Haw Par Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 151. Haw Par Recent Development
Table 152. Nichiban Company Details
Table 153. Nichiban Business Overview
Table 154. Nichiban Product
Table 155. Nichiban Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 156. Nichiban Recent Development
Table 157. Mentholatum Company Company Details
Table 158. Mentholatum Company Business Overview
Table 159. Mentholatum Company Product
Table 160. Mentholatum Company Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 161. Mentholatum Company Recent Development
Table 162. Laboratoires Genevrier Company Details
Table 163. Laboratoires Genevrier Business Overview
Table 164. Laboratoires Genevrier Product
Table 165. Laboratoires Genevrier Revenue in Transdermal Drug Delivery Systems Business (2015-2020) (Million US$)
Table 166. Laboratoires Genevrier Recent Development
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Transdermal Drug Delivery Systems Market Share by Type: 2020 VS 2026
Figure 2. Fentanyl Features
Figure 3. Nitroglycerin Features
Figure 4. Estradiol Features
Figure 5. Nicotine Features
Figure 6. Other Features
Figure 7. Global Transdermal Drug Delivery Systems Market Share by Application: 2020 VS 2026
Figure 8. OTC Case Studies
Figure 9. Rx Case Studies
Figure 10. Transdermal Drug Delivery Systems Report Years Considered
Figure 11. Global Transdermal Drug Delivery Systems Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Transdermal Drug Delivery Systems Market Share by Regions: 2020 VS 2026
Figure 13. Global Transdermal Drug Delivery Systems Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Transdermal Drug Delivery Systems Market Share by Players in 2019
Figure 16. Global Top Transdermal Drug Delivery Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Drug Delivery Systems as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Transdermal Drug Delivery Systems Revenue in 2019
Figure 18. North America Transdermal Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Transdermal Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Transdermal Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Transdermal Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Transdermal Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Transdermal Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Transdermal Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
高度ドラッグデリバリーシステムの世界市場（～2026年） Advanced drug delivery systems are the improved methods for delivering the drug molecule to the targeted site in a more controlled manner. These methods are developed in order to improve the efficacy ratio of the currently available drugs. Delivering drug at the controlled rate, slow and targeted de…- 鎮痛剤デリバリーの世界市場（～2026年） Drug delivery refers to approaches, formulations, technologies and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. Drug delivery is often approached via a drug's chemical formulation, but it may also involve medical devices o…
- 糖尿病治療・ドラッグデリバリーの世界市場（～2026年） Market Analysis and Insights: Global Diabetes Therapy and Drug Delivery Market The global Diabetes Therapy and Drug Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Diabetes Therapy and Drug Delivery Scope and …
- 次世代糖尿病治療・ドラッグデリバリーの世界市場（～2026年） Next generation diabetic therapy and drug delivery systems are used to improve the adherence to insulin in diabetic patients to reduce the risk of complications related to sudden change in the blood sugar level. The market growth is attributed to the rise in the number of diabetic patients globally …
- ドラッグデリバリーシステム（DDS）の世界市場（～2026年） Drug Delivery includes formulations, technologies, methods, and systems for transferring an active pharmaceutical ingredients into the body to safely provide therapeutic effect. Market Analysis and Insights: Global Drug Delivery Systems Market The global Drug Delivery Systems market size is projecte…